Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Hyaluronic-acid | hsa00030 | Pentose phosphate pathway | 2.88E-06 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Hyaluronic-acid | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Hyaluronic-acid | hsa00220 | Arginine biosynthesis | 1.54E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Hyaluronic-acid | hsa00500 | Starch and sucrose metabolism | 3.43E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Hyaluronic-acid | hsa00512 | Mucin type O-glycan biosynthesis | 2.27E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Hyaluronic-acid | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Hyaluronic-acid | hsa00600 | Sphingolipid metabolism | 3.24E-02 | 3 | Q9BX95, O14494, P06280 | SGPP1, PLPP1, GLA | More | | Hyaluronic-acid | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.29E-02 | 2 | P40925, P15104 | MDH1, GLUL | More | | Hyaluronic-acid | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Hyaluronic-acid | hsa00910 | Nitrogen metabolism | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Hyaluronic-acid | hsa00920 | Sulfur metabolism | 2.29E-02 | 1 | Q16762 | TST | More | | Hyaluronic-acid | hsa00970 | Aminoacyl-tRNA biosynthesis | 5.32E-03 | 3 | O95363, P54136, Q15046 | FARS2, RARS1, KARS | More | | Hyaluronic-acid | hsa00983 | Drug metabolism - other enzymes | 2.16E-03 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Hyaluronic-acid | hsa01040 | Biosynthesis of unsaturated fatty acids | 7.30E-03 | 2 | P22307, Q9H5J4 | SCP2, ELOVL6 | More | | Hyaluronic-acid | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | | Hyaluronic-acid | hsa01212 | Fatty acid metabolism | 7.30E-03 | 2 | Q9H5J4, P22307 | ELOVL6, SCP2 | More | | Hyaluronic-acid | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | | Hyaluronic-acid | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Hyaluronic-acid | hsa03013 | RNA transport | 4.09E-02 | 9 | P52298, Q09161, O14893, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, NCBP1, GEMIN2, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | | Hyaluronic-acid | hsa04060 | Cytokine-cytokine receptor interaction | 1.74E-04 | 17 | P14784, P27930, P14778, P08476, P26842, Q06643, Q13651, Q9HBE5, P25024, Q9UBD3, P47992, P01375, P09341, P19875, P18510, P01730, Q93038 | IL2RB, IL1R2, IL1R1, INHBA, CD27, LTB, IL10RA, IL21R, CXCR1, XCL2, XCL1, TNF, CXCL1, CXCL2, IL1RN, CD4, TNFRSF25 | More | | Hyaluronic-acid | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 3.36E-04 | 9 | P09341, P19875, P25024, P25025, P47992, Q9UBD3, Q13651, P14784, P01375 | CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL10RA, IL2RB, TNF | More | | Hyaluronic-acid | hsa04062 | Chemokine signaling pathway | 7.52E-04 | 9 | P25024, P09341, P19875, P07948, P42338, P19174, P63218, P50151, P43250 | CXCR1, CXCL1, CXCL2, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6 | More | | Hyaluronic-acid | hsa04064 | NF-kappa B signaling pathway | 5.22E-11 | 22 | P10415, Q13489, P25963, P51617, O00463, P14778, P01375, P29965, P19174, Q04759, Q9UDY8, Q13077, Q16548, P07948, P06239, Q8WV28, Q13315, P24522, O75293, P09341, P19875, Q06643 | BCL2, BIRC3, NFKBIA, IRAK1, TRAF5, IL1R1, TNF, CD40LG, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LYN, LCK, BLNK, ATM, GADD45A, GADD45B, CXCL1, CXCL2, LTB | More | | Hyaluronic-acid | hsa04071 | Sphingolipid signaling pathway | 2.81E-05 | 7 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2 | More | | Hyaluronic-acid | hsa04080 | Neuroactive ligand-receptor interaction | 1.76E-05 | 10 | P08311, P28472, Q15722, P21453, Q9H228, O00398, P21462, P21730, Q16581, P07550 | CTSG, GABRB3, LTB4R, S1PR1, EDG8, P2RY10, FPR1, C5AR1, C3AR1, ADRB2 | More | | Hyaluronic-acid | hsa04115 | p53 signaling pathway | 3.57E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | | Hyaluronic-acid | hsa04120 | Ubiquitin mediated proteolysis | 2.59E-03 | 12 | Q9UBT2, Q14145, Q15034, Q13042, Q9UJX4, Q93034, Q13049, Q13489, Q9UMS4, Q05086, P62837, Q15751 | SAE2, KEAP1, HERC3, CDC16, ANAPC5, CUL5, TRIM32, BIRC3, PRPF19, UBE3A, UBE2D2, HERC1 | More | | Hyaluronic-acid | hsa04122 | Sulfur relay system | 2.29E-02 | 1 | Q16762 | TST | More | | Hyaluronic-acid | hsa04145 | Phagosome | 1.44E-04 | 10 | Q15080, P14598, Q13509, P68371, Q13488, P05164, P78380, O60603, P35443, P13765 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Hyaluronic-acid | hsa04210 | Apoptosis | 1.09E-03 | 12 | Q13315, P10415, Q13489, O76075, P25963, P01375, P24522, Q16548, Q13077, P43234, P18848, Q14643 | ATM, BCL2, BIRC3, DFFB, NFKBIA, TNF, GADD45A, BCL2A1, TRAF1, CTSO, ATF4, ITPR1 | More | | Hyaluronic-acid | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Hyaluronic-acid | hsa04217 | Necroptosis | 2.34E-02 | 4 | P01375, P48023, Q14765, Q99878 | TNF, FASLG, STAT4, H2AC14 | More | | Hyaluronic-acid | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.95E-02 | 4 | P07550, P22694, P18848, Q13362 | ADRB2, PRKACB, ATF4, PPP2R5C | More | | Hyaluronic-acid | hsa04340 | Hedgehog signaling pathway | 4.63E-02 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | | Hyaluronic-acid | hsa04512 | ECM-receptor interaction | 2.00E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Hyaluronic-acid | hsa04514 | Cell adhesion molecules | 3.82E-02 | 2 | P16109, O00501 | SELP, CLDN5 | More | | Hyaluronic-acid | hsa04540 | Gap junction | 3.11E-02 | 4 | P17252, Q13509, P68371, Q14643 | PRKCA, TUBB3, TUBB2C, ITPR1 | More | | Hyaluronic-acid | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Hyaluronic-acid | hsa04611 | Platelet activation | 2.25E-04 | 4 | P08514, Q15746, Q8WYR1, P07359 | ITGA2B, MYLK, PIK3R5, GP1BA | More | | Hyaluronic-acid | hsa04612 | Antigen processing and presentation | 6.19E-08 | 9 | P13765, P48382, Q14953, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KIR2DS5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Hyaluronic-acid | hsa04613 | Neutrophil extracellular trap formation | 9.28E-06 | 17 | P17252, P16109, O60603, P05164, P08246, Q9UM07, Q6FI13, Q99878, P14598, Q15080, P20160, P08311, P49913, P21730, P08514, P21462, P07359 | PRKCA, SELP, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, H2AC14, NCF1, NCF4, AZU1, CTSG, CAMP, C5AR1, ITGA2B, FPR1, GP1BA | More | | Hyaluronic-acid | hsa04621 | NOD-like receptor signaling pathway | 3.10E-03 | 11 | Q14643, P25963, Q13489, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P49913, P12838 | ITPR1, NFKBIA, BIRC3, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CAMP, DEFA4 | More | | Hyaluronic-acid | hsa04640 | Hematopoietic cell lineage | 2.66E-04 | 13 | P13612, P14778, P27930, P11215, P15144, P25063, P07766, P09693, P01732, P01730, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOB, TNF | More | | Hyaluronic-acid | hsa04650 | Natural killer cell mediated cytotoxicity | 4.18E-09 | 12 | P19174, P01375, P06239, O60880, P20963, P42338, Q13241, P26718, O75015, P26717, Q14953, P26715 | PLCG1, TNF, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, FCGR3B, KLRC2, KIR2DS5, KLRC1 | More | | Hyaluronic-acid | hsa04657 | IL-17 signaling pathway | 7.59E-05 | 8 | O00463, Q16539, P49841, P09341, P19875, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, CXCL2, MMP9, LCN2, TNF | More | | Hyaluronic-acid | hsa04658 | Th1 and Th2 cell differentiation | 1.80E-10 | 14 | Q04759, P07766, P20963, P09693, Q16539, P19174, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Hyaluronic-acid | hsa04659 | Th17 cell differentiation | 9.49E-08 | 14 | Q04759, Q16539, P19174, P01730, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, MAPK14, PLCG1, CD4, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, CD3E, CD3G, CD247 | More | | Hyaluronic-acid | hsa04660 | T cell receptor signaling pathway | 8.34E-08 | 18 | P01375, P25963, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841 | TNF, NFKBIA, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3B | More | | Hyaluronic-acid | hsa04662 | B cell receptor signaling pathway | 3.70E-05 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Hyaluronic-acid | hsa04664 | Fc epsilon RI signaling pathway | 5.47E-04 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Hyaluronic-acid | hsa04666 | Fc gamma R-mediated phagocytosis | 4.40E-02 | 4 | P06396, O14494, P14598, P17252 | GSN, PLPP1, NCF1, PRKCA | More | | Hyaluronic-acid | hsa04668 | TNF signaling pathway | 3.12E-04 | 11 | P01375, O00463, Q13489, Q16539, P25963, P18848, P09341, P19875, P20749, Q13077, P14780 | TNF, TRAF5, BIRC3, MAPK14, NFKBIA, ATF4, CXCL1, CXCL2, BCL3, TRAF1, MMP9 | More | | Hyaluronic-acid | hsa04670 | Leukocyte transendothelial migration | 4.20E-02 | 7 | P14780, Q96A32, P17252, P14598, Q15080, Q08881, P42681 | MMP9, MYLPF, PRKCA, NCF1, NCF4, ITK, TXK | More | | Hyaluronic-acid | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Hyaluronic-acid | hsa04723 | Retrograde endocannabinoid signaling | 4.40E-02 | 4 | Q14643, P17252, P62873, Q16718 | ITPR1, PRKCA, GNB1, NDUFA5 | More | | Hyaluronic-acid | hsa04724 | Glutamatergic synapse | 3.69E-04 | 4 | P43003, P63218, P50151, P15104 | SLC1A3, GNG5, GNG10, GLUL | More | | Hyaluronic-acid | hsa04725 | Cholinergic synapse | 3.88E-04 | 9 | P22694, Q14643, P17252, P62873, P63218, P50151, P18848, P42338, P10415 | PRKACB, ITPR1, PRKCA, GNB1, GNG5, GNG10, ATF4, PIK3CB, BCL2 | More | | Hyaluronic-acid | hsa04727 | GABAergic synapse | 1.14E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Hyaluronic-acid | hsa04744 | Phototransduction | 1.70E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Hyaluronic-acid | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.06E-03 | 8 | P14778, P22694, Q16539, P19174, P42338, Q14643, P24723, Q04759 | IL1R1, PRKACB, MAPK14, PLCG1, PIK3CB, ITPR1, PRKCH, PRKCQ | More | | Hyaluronic-acid | hsa04913 | Ovarian steroidogenesis | 2.54E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Hyaluronic-acid | hsa04915 | Estrogen signaling pathway | 2.25E-02 | 5 | P14780, P22694, P18848, Q14643, P10415 | MMP9, PRKACB, ATF4, ITPR1, BCL2 | More | | Hyaluronic-acid | hsa04918 | Thyroid hormone synthesis | 2.91E-02 | 3 | P22694, P18848, Q14643 | PRKACB, ATF4, ITPR1 | More | | Hyaluronic-acid | hsa04920 | Adipocytokine signaling pathway | 4.49E-02 | 4 | P25963, P33121, Q04759, P01375 | NFKBIA, ACSL1, PRKCQ, TNF | More | | Hyaluronic-acid | hsa04921 | Oxytocin signaling pathway | 4.91E-02 | 2 | Q15746, Q8WYR1 | MYLK, PIK3R5 | More | | Hyaluronic-acid | hsa04924 | Renin secretion | 4.04E-02 | 2 | P22694, P07550 | PRKACB, ADRB2 | More | | Hyaluronic-acid | hsa04926 | Relaxin signaling pathway | 2.41E-02 | 4 | P18848, P22694, P14780, P30679 | ATF4, PRKACB, MMP9, GNA15 | More | | Hyaluronic-acid | hsa04927 | Cortisol synthesis and secretion | 3.58E-04 | 3 | Q14643, P18848, P22694 | ITPR1, ATF4, PRKACB | More | | Hyaluronic-acid | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.60E-02 | 5 | Q14643, P22694, P23771, P18848, P10415 | ITPR1, PRKACB, GATA3, ATF4, BCL2 | More | | Hyaluronic-acid | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | | Hyaluronic-acid | hsa04934 | Cushing syndrome | 4.06E-02 | 5 | Q14643, P22694, P49841, Q9UJU2, O00170 | ITPR1, PRKACB, GSK3B, LEF1, AIP | More | | Hyaluronic-acid | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Hyaluronic-acid | hsa04964 | Proximal tubule bicarbonate reclamation | 2.74E-03 | 3 | P22748, P00918, P49448 | CA4, CA2, GLUD2 | More | | Hyaluronic-acid | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Hyaluronic-acid | hsa04970 | Salivary secretion | 2.82E-03 | 5 | P07550, P22694, Q14643, P17252, P49913 | ADRB2, PRKACB, ITPR1, PRKCA, CAMP | More | | Hyaluronic-acid | hsa04973 | Carbohydrate digestion and absorption | 6.19E-05 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Hyaluronic-acid | hsa05020 | Prion disease | 4.24E-02 | 7 | Q16718, O14521, Q14643, Q13509, P68371, P14598, Q15080 | NDUFA5, SDHD, ITPR1, TUBB3, TUBB2C, NCF1, NCF4 | More | | Hyaluronic-acid | hsa05031 | Amphetamine addiction | 4.32E-02 | 3 | P22694, P18848, Q13547 | PRKACB, ATF4, HDAC1 | More | | Hyaluronic-acid | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P07948 | CXCL1, CXCL2, PLCG1, CXCR1, LYN | More | | Hyaluronic-acid | hsa05131 | Shigellosis | 3.34E-02 | 11 | P01375, P25963, O00463, Q04759, Q9UDY8, Q9H1Y0, Q14643, Q12778, Q13315, P10415, Q96A32 | TNF, NFKBIA, TRAF5, PRKCQ, MALT1, ATG5, ITPR1, FOXO1, ATM, BCL2, MYLPF | More | | Hyaluronic-acid | hsa05132 | Salmonella infection | 7.50E-04 | 13 | P51617, P25963, P01375, Q9UJU2, Q13489, P10415, O75369, Q96A32, O60603, Q9BQS8, Q13561, Q13509, P68371 | IRAK1, NFKBIA, TNF, LEF1, BIRC3, BCL2, FLNB, MYLPF, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C | More | | Hyaluronic-acid | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Hyaluronic-acid | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Hyaluronic-acid | hsa05135 | Yersinia infection | 4.26E-02 | 6 | P13612, P06239, Q16539, P01375, P49841, P01732 | ITGA4, LCK, MAPK14, TNF, GSK3B, CD8A | More | | Hyaluronic-acid | hsa05140 | Leishmaniasis | 3.22E-04 | 8 | P14598, P13765, O60603, P25963, P01375, P29350, P51617, Q15080 | NCF1, HLA-DOB, TLR2, NFKBIA, TNF, PTPN6, IRAK1, NCF4 | More | | Hyaluronic-acid | hsa05143 | African trypanosomiasis | 7.50E-04 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Hyaluronic-acid | hsa05144 | Malaria | 9.36E-05 | 6 | P69905, P68871, O60603, P01375, P35443, P26718 | HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | | Hyaluronic-acid | hsa05145 | Toxoplasmosis | 3.09E-03 | 8 | P51617, P25963, P01375, P10415, Q13489, P13765, O60603, P29965 | IRAK1, NFKBIA, TNF, BCL2, BIRC3, HLA-DOB, TLR2, CD40LG | More | | Hyaluronic-acid | hsa05146 | Amoebiasis | 6.14E-11 | 14 | Q13751, P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P30679, P22694, P12814, P08311 | LAMB3, CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, GNA15, PRKACB, ACTN1, CTSG | More | | Hyaluronic-acid | hsa05150 | Staphylococcus aureus infection | 3.32E-02 | 2 | Q14532, P16109 | KRT32, SELP | More | | Hyaluronic-acid | hsa05152 | Tuberculosis | 2.03E-04 | 10 | Q13488, P0DP23, P48382, O60603, P01375, P10415, P13765, P49913, Q9UDY8, P51617 | TCIRG1, CALM1, RFX5, TLR2, TNF, BCL2, HLA-DOB, CAMP, MALT1, IRAK1 | More | | Hyaluronic-acid | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Hyaluronic-acid | hsa05161 | Hepatitis B | 2.33E-02 | 8 | P17252, P14780, P25963, P01375, P10415, P51617, O60603, Q14765 | PRKCA, MMP9, NFKBIA, TNF, BCL2, IRAK1, TLR2, STAT4 | More | | Hyaluronic-acid | hsa05163 | Human cytomegalovirus infection | 2.64E-02 | 7 | P42338, P63218, P50151, P01106, P14778, Q13651, P30101 | PIK3CB, GNG5, GNG10, MYC, IL1R1, IL10RA, PDIA3 | More | | Hyaluronic-acid | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 7.60E-03 | 8 | P42338, P63218, P50151, P09341, P19875, P19174, P07948, P01106 | PIK3CB, GNG5, GNG10, CXCL1, CXCL2, PLCG1, LYN, MYC | More | | Hyaluronic-acid | hsa05169 | Epstein-Barr virus infection | 1.27E-02 | 9 | P01106, Q13547, P42338, P07948, P30101, Q13761, O75293, P07766, P20963 | MYC, HDAC1, PIK3CB, LYN, PDIA3, RUNX3, GADD45B, CD3E, CD247 | More | | Hyaluronic-acid | hsa05170 | Human immunodeficiency virus 1 infection | 3.65E-06 | 23 | P42338, P62873, P63218, P50151, P0DP23, P01375, P17252, O00463, P30101, Q14643, P01730, P51617, P25963, O60603, Q13315, O95067, P19174, P07766, P20963, P10415, Q13619, Q93034, Q9Y6Q5 | PIK3CB, GNB1, GNG5, GNG10, CALM1, TNF, PRKCA, TRAF5, PDIA3, ITPR1, CD4, IRAK1, NFKBIA, TLR2, ATM, CCNB2, PLCG1, CD3E, CD247, BCL2, CUL4A, CUL5, AP1M2 | More | | Hyaluronic-acid | hsa05202 | Transcriptional misregulation in cancer | 4.23E-07 | 17 | Q12778, Q15532, Q13315, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Hyaluronic-acid | hsa05205 | Proteoglycans in cancer | 7.57E-04 | 13 | Q13009, Q12955, Q14643, O75369, P14780, P17252, O60603, P01375, P23588, Q13635, P22694, P29350, P08962 | TIAM1, ANK3, ITPR1, FLNB, MMP9, PRKCA, TLR2, TNF, EIF4B, PTCH1, PRKACB, PTPN6, CD63 | More | | Hyaluronic-acid | hsa05217 | Basal cell carcinoma | 3.39E-02 | 4 | Q13635, P49841, Q9UJU2, P24522 | PTCH1, GSK3B, LEF1, GADD45A | More | | Hyaluronic-acid | hsa05222 | Small cell lung cancer | 2.79E-02 | 6 | Q13489, P10415, P25963, Q13077, O00463, P24522 | BIRC3, BCL2, NFKBIA, TRAF1, TRAF5, GADD45A | More | | Hyaluronic-acid | hsa05231 | Choline metabolism in cancer | 2.23E-02 | 3 | P42338, O15245, Q9Y259 | PIK3CB, SLC22A1, CHKB | More | | Hyaluronic-acid | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 6.30E-05 | 10 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, PRKCQ, MAPK14, CD4 | More | | Hyaluronic-acid | hsa05310 | Asthma | 6.41E-06 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Hyaluronic-acid | hsa05321 | Inflammatory bowel disease | 2.32E-10 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Hyaluronic-acid | hsa05322 | Systemic lupus erythematosus | 4.90E-03 | 9 | P08246, P08311, P01375, P10747, P13765, Q6FI13, Q16778, P12814, P05455 | ELA2, CTSG, TNF, CD28, HLA-DOB, H2AC18; H2AC19, HIST2H2BE, ACTN1, SSB | More | | Hyaluronic-acid | hsa05323 | Rheumatoid arthritis | 2.72E-02 | 4 | P01375, P13765, P09341, O60603 | TNF, HLA-DOB, CXCL1, TLR2 | More | | Hyaluronic-acid | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Hyaluronic-acid | hsa05332 | Graft-versus-host disease | 5.49E-09 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Hyaluronic-acid | hsa05340 | Primary immunodeficiency | 3.11E-02 | 4 | P29965, P10966, Q8WV28, P48382 | CD40LG, CD8B, BLNK, RFX5 | More | | Hyaluronic-acid | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Hyaluronic-acid | hsa05418 | Fluid shear stress and atherosclerosis | 3.50E-02 | 4 | P42338, P10599, P14778, P27930 | PIK3CB, TXN, IL1R1, IL1R2 | More | | |